FARXIGA
Drug timelines are a Plus or Pro feature.
120 regulatory and trial events tracked for FARXIGA, covering 2012-06-01 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy [NA]